官方服务：
资源简介：
Table scoring PD-L1 and CD47 intensity and %TC expression
应用场景：
创建时间：
2019-06-28
相关数据集
Supplementary Data from Pan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune Evasion
Supplementary Data from Pan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune Evasion
NIAID Data Ecosystem40
Means (SD/GSD) of age, U-Cd, U-β2M, and U-NAG of 269 participants in county A (CA) and 225 participants in county B (CB) △.
△Values of U-Cd, U-β2M, and U-NAG are expressed as GM and GSD, and values of age were calculated by arithmetic mean and SD.*Compared with the control group, PU-β2M, urinary level of β2-microglobulin;
Figshare2015-12-02 更新10
IMMUNE CHECKPOINT INHIBITORS IN SOLID TUMORS: MECHANISMS, CLINICAL EFFICACY, BIOMARKER-GUIDED PATIENT SELECTION, AND IMMUNE-RELATED ADVERSE EVENTS
Background: Immune checkpoint inhibitors (ICIs)—monoclonal antibodies blocking the PD-1/PD-L1 and CTLA-4 inhibitory pathways—have transformed the management of multiple advanced solid tumors, producin
Zenodo2026-03-26 更新10
Data Sheet 1_Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.pdf
Resistance to the currently available treatment paradigms is one of the main factors that contributes to poor outcomes in patients with advanced cervical cancer. Novel targeted therapy approaches migh
NIAID Data Ecosystem20
DataSheet_1_Clinical outcomes of immune checkpoint inhibitor combined with other targeted or immunological therapy regimens for the treatment of advanced bile tract cancer: a systematic review and meta-analysis.docx
Background and aimsA single immune checkpoint inhibitor (ICI) regimen has limited value in treating advanced bile tract cancer (BTC); therefore, ICI combination therapy is often applied. This meta-ana
NIAID Data Ecosystem10
